Tislelizumab,Sorafenib
BeiGene,Novartis
[]
 without an intention to r0 surgery/transplantation approach and actually do it, i d speculate that, with an only 20% response rate in this cohort suggest that not much will change soon !
Hepatopancreatobiliary & Transplant Surgeon @ Bahçeşehir University School of Medicine Medical Park Göztepe Hospital, Istanbul. Liv Ulus Hospital.